KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Cash from Financing Activities (2016 - 2026)

Tenet Healthcare (THC) has disclosed Cash from Financing Activities for 18 consecutive years, with -$1.2 billion as the latest value for Q1 2026.

  • For Q1 2026, Cash from Financing Activities fell 91.36% year-over-year to -$1.2 billion; the TTM value through Mar 2026 reached -$3.0 billion, down 79.01%, while the annual FY2025 figure was -$2.4 billion, 34.84% up from the prior year.
  • Cash from Financing Activities hit -$1.2 billion in Q1 2026 for Tenet Healthcare, down from -$434.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at -$33.0 million in Q2 2022 and bottomed at -$2.7 billion in Q1 2024.
  • Average Cash from Financing Activities over 5 years is -$596.6 million, with a median of -$372.0 million recorded in 2024.
  • Year-over-year, Cash from Financing Activities surged 88.28% in 2022 and then plummeted 943.53% in 2024.
  • Tenet Healthcare's Cash from Financing Activities stood at -$465.0 million in 2022, then soared by 31.83% to -$317.0 million in 2023, then fell by 17.35% to -$372.0 million in 2024, then decreased by 16.67% to -$434.0 million in 2025, then crashed by 185.71% to -$1.2 billion in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at -$1.2 billion, -$434.0 million, and -$323.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.